Advertisement

 

 

[Immunization strategy of hepatitis B vaccine among adults in China: evidence based-medicine and consideration].

Author Information (click to view)

Xu AQ, Zhang L,


Xu AQ, Zhang L, (click to view)

Xu AQ, Zhang L,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 50(6) 473-7 doi 10.3760/cma.j.issn.0253-9624.2016.06.001

Abstract

With the effective control of hepatitis B infection among children, the adults especial the young ones become the main population for new hepatitis B virus infection. Now the adults receive hepatitis B vaccination voluntarily and at their own expense in China and the coverage is low. The high immunogenicity of hepatitis B vaccine has been proven among healthy adults. Although the safety of hepatitis B vaccination has been documented among high-risk population such as HIV-infected people, injecting drug users and patients with chronic hepatitis disease, their antibody seroconversion rate after hepatitis B vaccination is lower than the healthy adults. Hepatitis B vaccination is recommended to population at high risk officially in many countries and some effects have been achieved. It is urgent to improve the strategy of hepatitis B vaccination among adults to fasten the control of hepatitis B in China, along with the researches about the long-term efficacy of hepatitis B vaccine among adults, the immunogenicity of hepatitis B vaccination among high-risk adults and the economical evaluation about different adult immunization strategy of hepatitis B.

Submit a Comment

Your email address will not be published. Required fields are marked *

sixteen + nineteen =

[ HIDE/SHOW ]